Chicos FAS (CHS) Tops Q3 EPS by 1c

Chicos FAS (NYSE: CHS) reported Q3 EPS of $0.11, $0.01 better than the analyst estimate of $0.10. Revenue for the quarter came in at $505.1 million versus the consensus estimate of $512.65 million.

Conference Call and Outlook

Given the pending acquisition by Sycamore Partners, the Company is not conducting a conference call for the third quarter. In addition, the Company is not providing a financial outlook and is withdrawing its previously issued outlook for fiscal 2023.

For earnings history and earnings-related data on Chicos FAS (CHS) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Reddit surges premarket on index inclusion; Applied Materials’ dips
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c